Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
RaySearch Laboratories AB ( ($SE:RAY.B) ) has shared an update.
RaySearch Laboratories has appointed Professor Antony Lomax, a leading pioneer in proton therapy, as Clinical Ambassador Particle Therapy to support its strategic development in particle therapy and emerging treatment technologies. He will join the newly created Corporate Development and Strategy department on August 12, 2026, bolstering RaySearch’s efforts to advance particle treatments and new modalities in radiation oncology.
Lomax, who has spent more than three decades at Switzerland’s Paul Scherrer Institute and helped turn proton therapy from an experimental concept into a clinical standard, brings deep scientific and clinical expertise to the company. His appointment is expected to strengthen RaySearch’s position in the growing field of particle therapy and enhance its relevance for customers, partners, investors, and the broader oncology community.
More about RaySearch Laboratories AB
RaySearch Laboratories AB is a Swedish medical technology company specializing in software for advanced cancer treatment, including its flagship RayStation treatment planning system and RayCare oncology information system. The company also offers RayIntelligence for oncology analytics and RayCommand for treatment control, serving over 1,200 clinics in 51 countries and listed on Nasdaq Stockholm since 2003.
Average Trading Volume: 162,615
Technical Sentiment Signal: Buy
Current Market Cap: SEK6.86B
For a thorough assessment of RAY.B stock, go to TipRanks’ Stock Analysis page.